MedPath

Discovery of new biomarkers related with disease progression in hardly curable malignant hematologic diseases

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0000414
Lead Sponsor
Seoul National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Bone marrow and saliva obtained from patients, who make diagnose with hardly curable malignant hematologic disese in Seoul National University Hospital

Exclusion Criteria

patients do not sign in informed consent

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
somatic muation and de novo mutation
Secondary Outcome Measures
NameTimeMethod
Death ;Relapse;Response of chemotherapy
© Copyright 2025. All Rights Reserved by MedPath